Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

58.20p
   
  • Change Today:
    -3.90p
  • 52 Week High: 121.60
  • 52 Week Low: 35.30
  • Currency: UK Pounds
  • Shares Issued: 540.00m
  • Volume: 902,616
  • Market Cap: £314.28m
  • RiskGrade: 119

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Peter Butterfield 672,687 £391,504
David Cook 234,129 £136,263
Andrew Franklin 128,384 £74,720
Richard Jones 15,000 £8,730

Major Shareholders

Notifier** Holding Value*
DBAY Advisors Limited 55,734,204 £32,437,307
MVM Life Science Partners 40,561,900 £23,607,026
Slater Investments Ltd 38,846,041 £22,608,396
Blackrock, Inc. 32,282,356 £18,788,331
Kempen Capital Management N.V. 26,621,969 £15,493,986
GVQ Investment Management Ltd 23,691,460 £13,788,430
FMR LLC 23,287,384 £13,553,258
Polar Capital 23,252,692 £13,533,067
Investec Asset Management 19,844,776 £11,549,660
Rathbone Investment Mgt 18,294,618 £10,647,468
Aviva plc & its subsidiaries 18,255,256 £10,624,559
Royal Bank of Canada 16,546,166 £9,629,869
Artemis Investment Management LLP 16,304,802 £9,489,395
Stella Anne Dawson 15,576,323 £9,065,420
Old Mutual Asset Managers (UK) Ltd 7,488,920 £4,358,551

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 58.20p
Change Today -3.90p
% Change -6.28 %
52 Week High 121.60
52 Week Low 35.30
Volume 902,616
Shares Issued 540.00m
Market Cap £314.28m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.01% below the market average66.01% below the market average66.01% below the market average66.01% below the market average66.01% below the market average
59.32% below the sector average59.32% below the sector average59.32% below the sector average59.32% below the sector average59.32% below the sector average
Price Trend
58.06% below the market average58.06% below the market average58.06% below the market average58.06% below the market average58.06% below the market average
6.45% above the sector average6.45% above the sector average6.45% above the sector average6.45% above the sector average6.45% above the sector average
Income
22.61% below the market average22.61% below the market average22.61% below the market average22.61% below the market average22.61% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Growth
19.47% below the market average19.47% below the market average19.47% below the market average19.47% below the market average19.47% below the market average
7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average

What The Brokers Say

Strong Buy 4
Buy 1
Neutral 2
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 22-Dec-22 09-Jun-22
Paid 19-Jan-23 07-Jul-22
Amount 0.59p 1.13p

Trades for 20-Mar-2023

Time Volume / Share Price
16:15 5 @ 57.91p
16:04 1,660 @ 58.20p
16:04 861 @ 58.20p
16:04 468 @ 58.20p
16:04 764 @ 58.20p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page